The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer’s disease models
Cell · 2026-11
DOI: 10.1016/j.cell.2026.10.039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-11. Verfasst von Haoyue Zhou und 29 weiteren Autor:innen. Beteiligte Einrichtung: Gladstone Institute of Neurological Disease, San Francisco, CA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BrightFocus Foundation, Cure Alzheimer's Fund, Carol and Gene Ludwig Family Foundation.
Themen: Demenz
Abstract (Originalsprache)
The blood-brain barrier (BBB) has been defined primarily by what it excludes, yet the scale and function of physiological blood-to-brain protein transport remain largely unknown. Using bioorthogonal proteomics, we find that the healthy BBB samples 191 plasma proteins and permits 92 into the brain parenchyma. Enriched for carrier and metabolic functions, these proteins home to distinct brain cell types, such as apolipoprotein A1 (APOA1) to astrocytes and alpha-1 antitrypsin (SERPINA1) to microglia. This cell-type tropism relies on a BBB-parenchyma receptor hand-off: APOA1 crosses the BBB via SR-B1 and engages astrocytic ATP-binding cassette transporter A1 (ABCA1), a key Alzheimer's risk gene, driving cholesterol efflux that supports synapse integrity. Unlike LPS-induced nonspecific leakage, early-stage 5xFAD mice show selective BBB transport remodeling, with reduced APOA1 and increased SERPINA1 uptake. Hepatic APOA1 overexpression restores APOA1 in the 5xFAD brain, rescuing astrocytic, synaptic, and behavioral deficits. These findings recast the BBB as a selective interface that recruits neuroprotective circulatory proteins for brain health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gladstone Institute of Neurological Disease, San Francisco, CA, USA.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
- Buck Institute for Research on Aging, Novato, CA, USA.
- Gladstone Institute of Neurological Disease, San Francisco, CA, USA; Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
- Gladstone Institute of Neurological Disease, San Francisco, CA, USA; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
- Gladstone Institute of Genomics Core, San Francisco, CA, USA.
Förderung
- BrightFocus Foundation
- Cure Alzheimer's Fund
- Carol and Gene Ludwig Family Foundation
- Dolby Family Ventures LP
- The Larry L Hillblom Foundation Inc
- Alzheimer's Association
- Burroughs Wellcome Fund
- National Institutes of Health
Zitieren
APA
Zhou, H., Maynard, J. C., Pennacchio, A. J., Apolonio, A., Liu, X., Yao, L., Negahban, M., Zhang, Z., Ding, B., Oberhauser, J., Wen, X., Yang, M. J., Huang, F., Chayama, Y., Doddipalli, S., Bernardi, M., Domke, L., Lo, I., Simms, J., …, & Yang, A. C. (2026). The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer’s disease models. Cell. https://doi.org/10.1016/j.cell.2026.10.039
Vancouver
Zhou H, Maynard JC, Pennacchio AJ, Apolonio A, Liu X, Yao L, et al. The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer’s disease models. Cell. 2026. doi:10.1016/j.cell.2026.10.039
BibTeX
@article{Zhou2026,
author = {Zhou, Haoyue and Maynard, Jason C and Pennacchio, Alexander J and Apolonio, Amanda and Liu, Xi and Yao, Lei and Negahban, Mina and Zhang, Zimo and Ding, Bella and Oberhauser, Jane and Wen, Xinlan and Yang, Myung Jin and Huang, Fionna and Chayama, Yuichi and Doddipalli, Sahith and Bernardi, Mylinh and Domke, Lane and Lo, Iris and Simms, Jeffrey and Pan, Andrew and Du, Sining and To, Ning-Sum and Wong, Pui Shuen and Duong, Duc and Fox, Eddie and Seyfried, Nicholas T and Cheung, Tom H and Tracy, Tara E and Burlingame, Alma L and Yang, Andrew C},
title = {The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer’s disease models},
journal = {Cell},
year = {2026},
doi = {10.1016/j.cell.2026.10.039}
}
EUVIMED